Post an Analysis Request an analysis AI Londinia analysis
EATON VANCE CORP.
EATON VANCE CORP.
- USD (-)
- 15 min delayed data - NYSE Stocks
Open: -
Change: -
Volume: -
Low: -
High: -
High / Low range: -
Type: Stocks
Ticker: ETW
ISIN:

Eaton Vance Corp. - Correction : Form 8 (DD) - Horizon Therapeutics Plc

  • 68
Eaton Vance Corp. - Correction : Form 8 (DD) - Horizon Therapeutics Plc

PR Newswire

London, January 27

This is an amendment of the notification sent 18th January regarding an in-kind
redemption from a Fund managed by EVM. The in-kind basket which included the
issuer was adjusted post-notification. The share amount of the issuer included
in the amended basket is 662 shares (previously 796 shares).


Ap13

FORM 8.1(c) & (d)(i)
(Dealing)

IRISH TAKEOVER PANEL

DEALING DISCLOSURE UNDER RULE 8.1(c) AND (d)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022

BY AN OFFEROR, OFFEREE OR PARTIES ACTING IN CONCERT WITH THEM IN RESPECT OF DEALINGS FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

1.             KEY INFORMATION

(a)  Full name of discloser: Eaton Vance Management 
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c)  Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree		 Horizon Therapeutics plc
(d) Status of person making the disclosure:

e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree)		 Horizon Therapeutics plc
(e)  Date dealing undertaken: 12 January 2023
(f)  In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”		 N/A

If YES, specify which:
 

Ap14

2.             INTERESTS AND SHORT POSITIONS

If there are positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (Note 1)

Class of relevant security:
(Note 2)		 Ordinary Shares
Interests Short positions
Number % Number %
(1)  Relevant securities owned and/or controlled: 36,456 0.02%
(2)  Cash-settled derivatives:
(3)  Stock-settled derivatives (including options) and agreements to purchase/sell:
Total: 36,456 0.02%

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 .

3.             DEALINGS BY THE PERSON MAKING THE DISCLOSURE (Note 3)

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

Ap15

(a)           Purchases and sales

(i)            Offeree, offeror or person acting in concert (except for a principal trader in the same group as a financial or other professional adviser acting in relation to the offer for the offeree or the offeror)

Class of
relevant
security		 Purchase/sale Number of
securities		 Price per unit
(Note 4)
Ordinary Shares

(ii)           Principal trader where the sole reason for the connection is that the principal trader is in the same group as a financial or other professional adviser acting in relation to the offer for the offeree or the offeror

Class of
relevant
security		 Purchases/
sales		 Total
number of
securities		 Highest
price per
unit paid/
received		 Lowest
price per
unit paid/
received

(b)           Cash-settled derivative transactions

Class of
relevant
security		 Product
description
e.g. CFD		 Nature of
dealing
e.g. opening/
closing a long/
short position,
increasing/
reducing a long/
short position		 Number of
reference
securities
(Note 5)		 Price
per unit
(Note 4)

Ap16

(c)           Stock-settled derivative transactions (including options)

(i)            Writing, selling, purchasing or varying

Class of
relevant
security		 Product
description
e.g. call
option		 Writing,
purchasing,
selling,
varying etc.		 Number
of
securities
to which
option
relates
(Note 5)		 Exercise
price per
unit		 Type
e.g.
American,
European
etc.		 Expiry
date		 Option
money
paid/
received
per unit

(ii)           Exercise

Class of
relevant
security		 Product
description
e.g. call
option		 Exercising/
exercised
against		 Number of
securities		 Exercise
price
per unit
(Note 4)

(d)           Other dealings (including transactions in respect of new securities)

Class of
relevant
security		 Nature of dealing
e.g. subscription,
conversion, exercise		 Details Price per unit
(if applicable)
(Note 4)
Ordinary shares This is an amendment of the notification sent 18th January regarding an in-kind redemption from a Fund managed by EVM.  The in-kind basket which included the issuer was adjusted post-notification.  The share amount of the issuer included in the amended basket is 662 shares (previously 796 shares).  EVM’s total interest in the issuer has been amended above. 662 Shares N/A

4.             OTHER INFORMATION

(a)           Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

Ap17

(b)           Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

(c)           Attachments

Is a Supplemental Form 8 attached? YES/NO
NO

   

Date of disclosure: 18th January 2023
Contact name: Scott R. Kudlacik
Telephone number: +00 1 617-672-6531
PR Newswire
PR Newswire

PR Newswire's news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.

NEW !